ADPT

Adaptive Biotechnologies Stock Analysis

AI Rating

Good
  • Quality2/10
  • Growth↑ 8/10
  • Momentum↑ 7/10
Adaptive Biotechnologies sales and earnings growth
ADPT Growth
Good
  • Revenue Y/Y↑ 42.57%
  • EPS Y/Y↑ 60.45%
  • FCF Y/Y↑ 45.05%
Adaptive Biotechnologies gross and profit margin trends
ADPT Profitability
Neutral
  • Gross margin ↑ 71.80%
  • EPS margin↓ -31.50%
  • ROIC↓ -14.60%
Adaptive Biotechnologies net debt vs free cash flow
ADPT Risk
Good
  • Debt / Equity↓ 1.0
  • Debt / FCF↓ 2.5
  • Interest coverage↓ -5.8

Adaptive Biotechnologies stock volatility is in-line with the overall market. We give it a Good risk rating.

More Biotechnology stocks ↗